Kalaris Therapeutics (KLRS) Current Leases (2019 - 2020)
Kalaris Therapeutics (KLRS) has 2 years of Current Leases data on record, last reported at $3.2 million in Q3 2020.
- For Q3 2020, Current Leases changed N/A year-over-year to $3.2 million; the TTM value through Sep 2020 reached $3.2 million, changed N/A, while the annual FY2019 figure was $3.1 million, N/A changed from the prior year.
- Current Leases reached $3.2 million in Q3 2020 per KLRS's latest filing, up from $3.1 million in the prior quarter.
- Across five years, Current Leases topped out at $3.2 million in Q3 2020 and bottomed at $3.1 million in Q4 2019.